ArticleJournal of medical Internet research2020
Benefits of Teledermatology for Geriatric Patients: Population-Based Cross-Sectional Study.
Article in Journal of medical Internet research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 46 citations in OpenAlex.
- Validation of a Dermatology-Focused Multimodal Image-and-Data Assistant in Diagnosis and Management of Common Dermatologic Conditions.Medicina (Kaunas, Lithuania) · 2026Article
- Review
- An update on the diagnosis and treatment of seborrheic keratosis.Frontiers in medicine · 2026Review
- Skin Cancer in Residential Care Facilities: A Scoping Review of Risk, Diagnosis, Psychosocial Impact, and Management.Cureus · 2026Review
- Validation of the Dermatologic Complexity Score for Dermatologic Triage.Diagnostics (Basel, Switzerland) · 2025Article
- Teledermatology: an evidence map of systematic reviews.Systematic reviews · 2024Article
- Skin health of community-living older people: a scoping review.Archives of dermatological research · 2024Article
- Virtual Consultation in Dermatology: Access Inequalities According to Socioeconomic Characteristics and the Place of Residence.Healthcare (Basel, Switzerland) · 2024Article
- Review
- Inequities in geriatric access to teledermatology and smartphone dermoscopy.Dermatology reports · 2023Article
- Evaluation of WhatsApp as a Platform for Teledermatology in Botswana: Retrospective Review and Survey.JMIR dermatology · 2022Article
- Teledermatology in Rural, Underserved, and Isolated Environments: A Review.Current dermatology reports · 2022Review
- Comanagement of Rashes by Primary Care Providers and Dermatologists: A Retrospective Study.The Permanente journal · 2021Article
- The Impact of COVID-19 on Teledermatology: A Review.Dermatologic clinics · 2021Review
- Teledermatology Consults in a County Hospital Setting: Retrospective Analysis.JMIR dermatology · 2021Article
- Factors Contributing to Diagnostic Discordance Between Store-and-Forward Teledermatology Consultations and In-Person Visits: Case Series.JMIR dermatology · 2021Article
- International Teledermatology Review.Current dermatology reports · 2021Review
- Teledermatology Addressing Disparities in Health Care Access: a Review.Current dermatology reports · 2021Review
- Teleoncology: The Youngest Pillar of Oncology.JCO global oncology · 2020Article
- Training of primary care physicians enhances performance of mobile teledermatology.Anais brasileiros de dermatologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTeledermatology is a health care tool that has been increasingly used around the world, mostly because dermatology has an emphasis on visual diagnosis. Many studies have shown that access to specialized care improves using teledermatology, which provides accurate diagnosis and reduces the time taken for treatment, with high patient satisfaction. As the population around the world grows old, there will be even more demand for dermatologists in years to come. It is essential to know which are the most prevalent skin conditions in the primary care population and if they can be addressed through teledermatology.
objectiveOur main goal was to evaluate the proportion of lesions in individuals aged 60 years and older that could be managed using teledermatology in conjunction with primary care physicians. Second, we aimed to assess the most frequent skin lesions, the most common treatments provided to patients, and the distribution and causes of referrals made by the teledermatologists.
methodsThis was a retrospective cohort study from July 2017 to July 2018 in São Paulo, Brazil. We included 6633 individuals aged 60 years and older who presented with 12,770 skin lesions. Teledermatologists had three options to refer patients: (1) to undergo biopsy directly, (2) to an in-person dermatologist visit, and (3) back to the primary care physician with the most probable diagnosis and treatment.
resultsTeledermatology managed 66.66% (8408/12614) of dermatoses with the primary care physician without the need for an in-presence visit; 27.10% (3419/12614) were referred to dermatologists, and 6.24% (787/12614) directly to biopsy. The most frequent diseases were seborrheic keratosis, solar lentigo, onychomycosis, melanocytic nevus, benign neoplasms, actinic keratosis, epidermoid cyst, xerosis, leucoderma, and wart, with significant differences between sexes. Malignant tumors increased with age and were the leading cause for biopsies, while infectious skin conditions and pigmentary disorders decreased. Emollient was the most frequent treatment prescribed, in 31.88% (909/2856) of the cases.
conclusionsTeledermatology helped to treat 67% of the dermatoses of older individuals, addressing cases of minor complexity quickly and conveniently together with the primary care physician, thus optimizing dermatological appointments for the most severe, surgical, or complex diseases. Teledermatology does not aim to replace a face-to-face visit with the dermatologist; however, it might help to democratize dermatological treatment access for patients and decrease health care expenses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.